Lawrence James L M, Tong Mei, Alfulaij Naghum, Sherrin Tessi, Contarino Mark, White Michael M, Bellinger Frederick P, Todorovic Cedomir, Nichols Robert A
Department of Cell and Molecular Biology, University of Hawai'i at Manoa, Honolulu, Hawaii 96813, and.
Department of Cell and Molecular Biology, University of Hawai'i at Manoa, Honolulu, Hawaii 96813, and Departments of Pharmacology and Physiology and.
J Neurosci. 2014 Oct 22;34(43):14210-8. doi: 10.1523/JNEUROSCI.0326-14.2014.
Soluble β-amyloid has been shown to regulate presynaptic Ca(2+) and synaptic plasticity. In particular, picomolar β-amyloid was found to have an agonist-like action on presynaptic nicotinic receptors and to augment long-term potentiation (LTP) in a manner dependent upon nicotinic receptors. Here, we report that a functional N-terminal domain exists within β-amyloid for its agonist-like activity. This sequence corresponds to a N-terminal fragment generated by the combined action of α- and β-secretases, and resident carboxypeptidase. The N-terminal β-amyloid fragment is present in the brains and CSF of healthy adults as well as in Alzheimer's patients. Unlike full-length β-amyloid, the N-terminal β-amyloid fragment is monomeric and nontoxic. In Ca(2+) imaging studies using a model reconstituted rodent neuroblastoma cell line and isolated mouse nerve terminals, the N-terminal β-amyloid fragment proved to be highly potent and more effective than full-length β-amyloid in its agonist-like action on nicotinic receptors. In addition, the N-terminal β-amyloid fragment augmented theta burst-induced post-tetanic potentiation and LTP in mouse hippocampal slices. The N-terminal fragment also rescued LTP inhibited by elevated levels of full-length β-amyloid. Contextual fear conditioning was also strongly augmented following bilateral injection of N-terminal β-amyloid fragment into the dorsal hippocampi of intact mice. The fragment-induced augmentation of fear conditioning was attenuated by coadministration of nicotinic antagonist. The activity of the N-terminal β-amyloid fragment appears to reside largely in a sequence surrounding a putative metal binding site, YEVHHQ. These findings suggest that the N-terminal β-amyloid fragment may serve as a potent and effective endogenous neuromodulator.
可溶性β-淀粉样蛋白已被证明可调节突触前钙(Ca2+)和突触可塑性。特别是,皮摩尔浓度的β-淀粉样蛋白被发现对突触前烟碱样受体具有激动剂样作用,并以依赖于烟碱样受体的方式增强长时程增强(LTP)。在此,我们报告β-淀粉样蛋白中存在一个功能性N端结构域,负责其激动剂样活性。该序列对应于由α-和β-分泌酶以及驻留羧肽酶共同作用产生的N端片段。N端β-淀粉样蛋白片段存在于健康成年人的大脑和脑脊液中,以及阿尔茨海默病患者体内。与全长β-淀粉样蛋白不同,N端β-淀粉样蛋白片段是单体且无毒。在使用模型重组啮齿动物神经母细胞瘤细胞系和分离的小鼠神经末梢进行的Ca2+成像研究中,N端β-淀粉样蛋白片段在对烟碱样受体的激动剂样作用方面被证明比全长β-淀粉样蛋白更有效且效力更强。此外,N端β-淀粉样蛋白片段增强了小鼠海马切片中θ波爆发诱导的强直后增强和LTP。N端片段还挽救了因全长β-淀粉样蛋白水平升高而受到抑制的LTP。在完整小鼠双侧海马背侧注射N端β-淀粉样蛋白片段后,情境恐惧条件反射也得到了强烈增强。烟碱拮抗剂的共同给药减弱了片段诱导的恐惧条件反射增强。N端β-淀粉样蛋白片段的活性似乎主要存在于围绕假定金属结合位点YEVHHQ的序列中。这些发现表明,N端β-淀粉样蛋白片段可能作为一种强效且有效的内源性神经调节剂发挥作用。